Back

Heart failure or ATTR-CM? The importance of early diagnosis.

22 May 2022 (14:55 - 15:00)
Organised by:
Congress Presentation Part of: Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)? Cardiac Diseases Open Access Heart Failure 2022

About the speaker

Photo
Doctor Jose Gonzalez-Costello

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

3 More presentations in this session

Presentation thumbnail
Clinical perspectives: raising suspicion and diagnosing ATTR-CM in patients with heart failure.
Associate Professor A. Pollak (Jerusalem, IL)
Slides Video
Presentation thumbnail
Long-term management of patients with ATTR-CM.
Professor C. Rapezzi (Ferrara, IT)
Slides Video
Presentation thumbnail
Panel discussion and Q&A.
Slides Video

Access the full session

Session thumbnail
Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)?

The Event

Event poster

Heart Failure 2022

22 May 2022 14:55 CET
You may be interested in
thumbnail
Congress Presentation
Welcome and introduction.
27 August 2022
thumbnail
Congress Presentation
Epidemiology of amyloidosis in heart failure and red flags
2 September 2024
thumbnail
Congress Session
Applying ATTR-CM data for optimal outcomes: from trials to clinical practice
12 May 2024
thumbnail
Congress Presentation
Heart failure with preserved ejection fraction in the elderly: when to suspect transthyrretin cardiac amyloidosis?
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources